SII’s Covovax granted emergency use approval for adults, children above 12
India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official sources said on Wednesday.
It is the…
Read More...
Read More...